ATON Partners, the newly formed brainchild of a pair of former women’s healthcare executives, plans to provide advisory services to medical device and in vitro diagnostics companies in early development.
Launched by Patrick Sullivan and Daniel Levangie, a former MassDevice winner for most innovative medtech CEOs, ATON is also looking for investment opportunities in medtech and product development.
Sullivan and Levangie once ran things at research and investing firm Cytyc Corporation, Sullivan as president & CEO and Levangie as executive vice president and president of the surgical division. The duo later formed Constitution Medical Investors and Constitution Medical Inc., which developed hematology systems and was earlier this year bought up by Roche Diagnostics (PINK:RHHBY) for $220 million plus milestones.
"With the integration of CMI with Roche Diagnostics now complete, we are excited to put our extensive experience to work in a new venture," Sullivan said in prepared remarks. "We are proud of our track record of success in creating value in the healthcare marketplace, and are looking forward to working with other talented management teams to provide guidance based upon our combined 50 years of experience in building great companies and significant shareholder value."
Sullivan was named one of MassDevice’s CEO Class of 2011, at which time he was steering the ship at Keystone Medical.